Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Therapeutic decision making in a new drug era in multiple sclerosis.
A correlation study between multiple sclerosis and type 1 diabetes incidences and geochemical data in Europe.
Dissection of a Complex Disease Susceptibility Region Using a Bayesian Stochastic Search Approach to Fine Mapping.
Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis.
Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies.
NMO-IgG positive relapsing longitudinally extensive transverse myelitis (LETM) in a seropositive HIV patient.
Living with multiple sclerosis.
Prediction of antibody persistency from antibody titres to natalizumab.
Cerebrospinal fluid and urinary biomarkers in multiple sclerosis.
Dysphagia in stroke, neurodegenerative disease, and advanced dementia.
Usability and Potential of Geostatistics for Spatial Discrimination of Multiple Sclerosis Lesion Patterns.
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
Sex-related differences of cAMP-specific PDE4B3 mRNA in oligodendrocytes following systemic inflammation.
Simulating neurodegeneration through longitudinal population analysis of structural and diffusion weighted MRI data.
The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS.
Developing a therapeutic plan for treating MS: evidence for new treatments.
Small and Long Regulatory RNAs in the Immune System and Immune Diseases.
Reply to Article: High inbreeding in the Faroe Islands does not appear to constitute a risk factor for multiple sclerosis.
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation.
Early and Degressive Putamen Atrophy in Multiple Sclerosis.
Association Between Physical Fitness and Cognitive Function in Multiple Sclerosis: Does Disability Status Matter?
Social and economic burden of walking and mobility problems in multiple sclerosis.
Clinical experience of natalizumab in Crohn's disease patients in a restricted distribution program.
Enhanced Action Potential Passage Through the Node of Ranvier of Myelinated Axons via Proton Hopping.
Pages
« first
‹ previous
…
280
281
282
283
284
285
286
287
288
…
next ›
last »